Dhanuka Agritech Limited reported a net profit of ₹36.30 crore for the quarter ended June 30, 2026 (Q1FY26), marking a 34.6% decline from the ₹55.50 crore recorded in the same period last year. Revenue from operations fell 12.6% to ₹461.93 crore, reflecting seasonal variations typical of the agrochemical sector. Despite the earnings contraction, the company’s Board of Directors approved significant strategic expansions, including a ₹200 crore pesticide manufacturing facility in Nagpur and a share buyback program worth ₹70 crore.

The financial results were reviewed by the Audit Committee and approved by the Board on August 3, 2026. S S Kothari Mehta & Co. LLP, the statutory auditors, conducted a limited review of the unaudited financial results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were prepared in accordance with Ind AS 34 and other generally accepted accounting principles in India.

Financial Performance Overview

Revenue from operations stood at ₹46,192.81 lakh for Q1FY26, compared to ₹52,828.81 lakh in Q1FY25. Other income decreased to ₹886.28 lakh from ₹804.38 lakh in the prior year quarter. Total expenses were ₹42,221.73 lakh, up from ₹46,178.63 lakh in Q1FY25, primarily due to lower material costs which dropped to ₹28,713.26 lakh from ₹36,145.86 lakh. However, other expenses rose to ₹6,094.09 lakh from ₹6,046.20 lakh.

Basic Earnings Per Share (EPS) declined to ₹8.06 from ₹12.31 in the corresponding quarter of FY25. For the nine months ended March 31, 2026, the company reported a net profit of ₹287.23 crore on revenue of ₹2,019.79 crore.

Strategic Expansions and Capital Allocation

The Board approved an investment of up to ₹200 crore to establish a pesticide manufacturing unit in Nagpur, Maharashtra. The new plant will have a capacity of 23,000 MT per annum and is expected to be operational by March or April 2028. Financing will be sourced through internal accruals and/or debt. Management cited logistical advantages, reduced lead times to prime markets in South, East, and Central India, and favorable industrial policies in Maharashtra as key rationales for the expansion.

Additionally, the Board sanctioned a loan of up to ₹15 crore to the proposed Dhanuka Employee Stock Benefits Trust. The funds will be used for the acquisition of equity shares from the open market and the administration of the "Dhanuka Stock Appreciation Rights Plan, 2026" (SAR 2026), in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Share Buyback Impact

During the quarter, Dhanuka Agritech bought back 500,000 fully paid-up equity shares at ₹1,400 per share, aggregating to ₹70 crore. The shares were extinguished on June 20, 2026. This buyback represented 1.11% of the total issued and paid-up equity capital and resulted in a reduction of paid-up share capital by ₹10 lakh. The remaining paid-up equity share capital stands at ₹891.57 lakh.

What the Numbers Show

The divergence between revenue decline (-12.6%) and expense reduction (-8.8%) highlights margin pressure in Q1FY26. While cost of materials consumed fell significantly, helping cushion the bottom line, the overall profit decline was sharper than revenue, indicating fixed cost rigidity or lower operating leverage. The strategic move to build a local manufacturing capacity in Nagpur aims to mitigate long-term logistical costs and supply chain dependencies, potentially improving future margins despite short-term headwinds.

Dhanuka Agritech reported a significant contraction in its standalone financial performance for the quarter ended June 30, 2026 (Q1FY27), with net profit falling 35% year-on-year to ₹3,630.44 lakh. The agrochemical company’s total income from operations declined 12% to ₹47,079.09 lakh from ₹53,633.19 lakh in the corresponding period of the previous year, reflecting broader pressure on top-line growth and profitability margins.

The results were approved by the Board of Directors in a meeting held on August 3, 2026, following a review by the Audit Committee. The unaudited financial statements were subjected to a limited review by the company’s statutory auditors. The detailed financial results were filed with the stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Q1FY27 Financial Performance

Dhanuka Agritech’s key financial metrics for the quarter highlight a sharp decline in operating efficiency and bottom-line earnings compared to the prior year.

Revenue from operations dropped to ₹47,079.09 lakh from ₹53,633.19 lakh in Q1FY26. Consequently, net profit before tax contracted by nearly 35% to ₹4,857.36 lakh from ₹7,454.56 lakh. The post-tax net profit stood at ₹3,630.44 lakh, down from ₹5,550.34 lakh in the year-ago quarter. Basic earnings per share (EPS) declined to ₹8.06 from ₹12.31.

Analytical Observation: Margin Compression

The decline in profitability outpaced the drop in revenue, indicating margin compression during the quarter. While revenue fell by approximately 12%, net profit before tax declined by nearly 35%. This divergence suggests rising operational costs or lower pricing power in the agrochemical segment, which weighed heavily on the company’s bottom line. Investors should monitor whether this margin erosion is a temporary seasonal effect or a structural shift in the competitive landscape.

Shareholder Information

The paid-up equity share capital remained stable at ₹891.57 lakh, compared to ₹901.57 lakh at the end of FY26. The company’s other equity reserves were nil for the quarter, whereas they stood at ₹1,67,286.30 lakh at the end of the fiscal year. Shareholders can access the full format of the quarterly financial results on the websites of BSE and NSE, as well as on the company’s official website.